The nation's largest commercial insurer recently started forcing physicians to jump through extra hoops before getting paid for certain outpatient services.
One publicly traded imaging center operator saw its stock climb 21% in the days after the U.S. FDA's approval of Aduhelm.
Also, Butterfly Network building a new headquarters, Hyperfine names a CEO, and ImaginAb raises $12.8 million in funding.
Absent passage of HR 3657, the profession is “in peril,” with RAs losing their jobs and left unable to practice to the full extent of their training, advocates said Monday.
The Society of Nuclear Medicine & Molecular Imaging said it’s received “many complaints” from the field pertaining to various commercial payers.
An uptake scan, for instance, could cost nearly five times as much within the same institution, depending on the patient’s insurer.
The two tech giants have now cleared a key hurdle to completing their merger, company officials revealed recently.
"This study shows what many radiologists probably already expect: That private insurers have instituted broad prior authorization policies," one expert told Radiology Business.
The American College of Radiology had urged the Hartford, Connecticut-based company to revise its payment policy to match new USPSTF guidelines.
Most nonhospital-based groups fall outside of the new CMS rule, but there’s still an opportunity to adopt this mindset and attract new customers, experts wrote recently.
Joel Rainwater, MD, just opened his flagship location in Gilbert, Arizona, housed in a 15,000-square-foot former Walmart Neighborhood Store.
Founded in 2011, the Shanghai-based firm recently scored U.S. FDA clearance for products tied to nuclear and MR imaging.